Page 498 - The Veterinary Laboratory and Field Manual 3rd Edition
P. 498

Antimicrobial resistance: a threat to human and animal health   435


                12.2  What can be done about             of antibiotics (such as requiring an infectious
                     antimicrobial resistance?           diseases consult, or pre-approval prior to use),
                                                         and computer assisted decision support tools.
                taking a one Health approach             Population-level interventions include pro-
                                                         motion of vaccinations, to reduce the risk of
                The concept of One Health recognizes that the   bacterial infections.
                health of humans, animals and the environment
                are interconnected (Figure 12.2). Application of   World Health Organization Global
                the concept to AMR requires interdisciplinary   Action Plan
                collaboration and communication between phy-
                sicians and veterinarians and the engagement   The World Health Organization (WHO) has
                of a wide range of expertise including micro-  recognized the  urgency and importance of
                biologists, environmental and wildlife experts,   addressing the rapid rise of antimicrobial resis-
                farm advisers and social scientists. Owing to   tance. They have published a Global Action
                the complexity of antimicrobial resistance it is   Plan, with five key objectives (World Health
                paramount that the issue is addressed by both   Organization, 2014).
                human health and veterinary authorities in a
                harmonious and collaborative way.        1  To improve understanding of AMR, through
                                                           education and training.
                                                         2  To strengthen the knowledge base surround-
                                                           ing  AMR  through  the  development  and
                                                           maintenance of surveillance and research.
                                                           Examples of knowledge gaps include the
                                                           need to understand how resistance circulates
                                                           among humans, animals and the environment,
                                                           and the need to identify non-antimicrobial
                                                           alternatives for use in agriculture.
                                                         3  To reduce infection rates through effective
                                                           infection prevention strategies.
                Figure 12.2  The One Health approach considers   4  To optimize antimicrobial use in human and
                the interactions in health among humans, animals,   animal populations.
                and the environment.                     5  To make an economic case for  sustainable
                                                           investment, and increasing investment in
                                                           new medicines, technologies and vaccina-
                antibiotics and human health
                                                           tions.
                Interventions targeting use of antibiotics
                in humans                                In addition to the WHO guidelines on the use of
                                                         antimicrobials important for human medicine,
                There has been a lot of work done to limit exces-  the World Organisation for Animal Health (OIE)
                sive use of antibiotics in human medicine, to   has developed a list of antimicrobial agents of
                slow the rise of AMR. These interventions are   veterinary importance (most recently updated
                often  aimed to change prescriber behaviour   in 2018) (OIE, 2018c), which should be consid-
                through education, audit and feedback, promo-  ered when contemplating antimicrobial therapy
                tion of the use of clinical guidelines, restriction   in animals (Figure 12.3). Antimicrobials of







       Vet Lab.indb   435                                                                  26/03/2019   10:26
   493   494   495   496   497   498   499   500   501   502   503